http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104398532-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7048 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J71-0005 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7048 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07J71-00 |
| filingDate | 2013-04-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2017-02-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2017-02-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-104398532-B |
| titleOfInvention | Application of cardiac glycoside compound 12beta-hydroxycalotropin |
| abstract | The invention discloses an application of a cardiac glycoside compound 12beta-hydroxycalotropin in preparation of medicine for treating and preventing tumors. The cardiac glycoside compound 12beta-hydroxycalotropin has remarkable antitumor activity and can be used as a lead compound for treating the tumors. Meanwhile, an extraction separation method of the cardiac glycoside compound 12beta-hydroxycalotropin is simple, practicable, low in cost, high in efficiency and yield and good in extraction quality. |
| priorityDate | 2013-04-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 40.